Proliferation and maturation of intratumoral blood vessels in non-small cell lung cancer

Human Pathology

Volumn 44, Issue 8, 2013, Pages 1586-1596

  Yazdani, Samaneh ^a   Miki, Yasuhiro ^a   Tamaki, Kentaro ^a,b   Ono, Katsuhiko ^a   Iwabuchi, Erina ^a   Abe, Keiko ^a   Suzuki, Takashi ^a   Sato, Yasufumi ^c   Kondo, Takashi ^c   Sasano, Hironobu ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Immunohistochemistry; Lung; Pericyte; Vasohibin 1

Indexed keywords

CD31 ANTIGEN; ENDOGLIN; KI 67 ANTIGEN; NESTIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE;

ANGIOGENESIS; IMMUNOHISTOCHEMISTRY; LUNG; PERICYTE; VASOHIBIN-1;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84880326815     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.01.004     Document Type: Article

References (35)

1. S. Ryuge, Y. Sato, and G.Q. Wang Prognostic significance of nestin expression in resected non-small cell lung cancer Chest 139 2011 862 869
2. Y. Yuan, F. Wang, X.H. Liu, D.J. Gong, H.Z. Cheng, and S.D. Huang Angiogenin is involved in lung adenocarcinoma cell proliferation and angiogenesis Lung Cancer 66 2009 28 36
3. H. Wakelee Antibodies to vascular endothelial growth factor in non-small cell lung cancer J Thorac Oncol 3 2008 113 118
4. F. Di Costanzo, F. Mazzoni, M. Micol Mela, L. Antonuzzo, D. Checcacci, and M. Saggese Bevacizumab in non-small cell lung cancer Drugs 68 2008 737 746
5. T. Shih, and C. Lindley Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies Clin Ther 28 2006 1779 1802
6. C. Manegold Bevacizumab for the treatment of advanced non-small-cell lung cancer Expert Rev Anticancer Ther 8 2008 689 699
7. R.S. Herbst, and A. Sandler Bevacizumab and erlotinib: a promising new approach to the treatment of advanced NSCLC Oncologist 13 2008 1166 1176
8. H. Kojima, N. Shijubo, and S. Abe Thymidine phosphorylase and vascular endothelial growth factor in patients with stage I lung adenocarcinoma Cancer 94 2002 1083 1093
9. K. Tamaki, T. Moriya, and Y. Sato Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis Cancer Sci 100 2009 88 94
10. K. Tamaki, H. Sasano, and Y. Maruo Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast Cancer Sci 101 2010 1051 1058
11. P.P. de Andrade Santos, A.R. de Aquino, A. Oliveira Barreto, F.R. de Almeida, H.C. Galvao, and L.B. de Souza Immunohistochemical expression of nuclear factor kappaB, matrix metalloproteinase 9, and endoglin (CD105) in odontogenic keratocysts, dentigerous cysts, and radicular cysts Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112 2011 476 483
12. G. Bergers, and S. Song The role of pericytes in blood-vessel formation and maintenance Neuro Oncol 7 2005 452 464
13. C. Lu, M.M. Shahzad, and M. Moreno-Smith Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models Cancer Biol Ther 9 2010 176 182
14. L.B. Rivera, and R.A. Brekken SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-beta1 activity J Cell Biol 193 2011 1305 1319
15. B. Nico, M.G. Ennas, and E. Crivellato Desmin-positive pericytes in the chick embryo chorioallantoic membrane in response to fibroblast growth factor-2 Microvasc Res 68 2004 13 19
16. A. Giatromanolaki, M.I. Koukourakis, E. Sivridis, K. O'Byrne, K.C. Gatter, and A.L. Harris 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer J Pathol 192 2000 140 149
17. A. Giatromanolaki, E. Sivridis, and G. Minopoulos Differential assessment of vascular survival ability and tumor angiogenic activity in colorectal cancer Clin Cancer Res 8 2000 1185 1191
18. Y. Yatabe, T. Takahashi, and T. Mitsudomi Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer Cancer Res 68 2008 2106 2111
19. J. Pyne, D. Sapkota, and J.C. Wong Aggressive basal cell carcinoma: dermatoscopy vascular features as clues to the diagnosis Dermatology Practical and Conceptual 2 2012 3 11
20. M. Ito, T. Moriya, and T. Ishida Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer Breast Cancer 14 2007 381 387
21. C.C. Hu, C. Zhang, Q. Qian, and N.B. Tatum Reparative dentin formation in rat molars after direct pulp capping with growth factors J Endod 24 1998 744 751
22. C. Ancuta, E. Ancuta, F. Zugun-Eloae, and E. Carasevici Neoangiogenesis in cervical cancer: focus on CD34 assessment Rom J Morphol Embryol 51 2010 289 294
23. T. Hosaka, H. Kimura, and T. Heishi Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis Am J Pathol 175 2009 430 439
24. K. El Gehani, L. Al-Kikhia, N. Mansuri, K. Syrjanen, O. Al-Fituri, and A. Elzagheid Angiogenesis in urinary bladder carcinoma as defined by microvessel density (MVD) after immunohistochemical staining for Factor VIII and CD31 Libyan J Med 2011 6
25. C. Morishita, E. Jin, and M. Kikuchi Angiogenic switching in the alveolar capillaries in primary lung adenocarcinoma and squamous cell carcinoma J Nihon Med Sch 74 2007 344 354
26. T. Shibusa, N. Shijubo, and S. Abe Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma Clin Cancer Res 4 1998 1483 1487
27. L.M. Wood, Z.K. Pan, P. Guirnalda, P. Tsai, M. Seavey, and Y. Paterson Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105 Cancer Immunol Immunother 60 2011 931 942
28. N. Eleno, A. Duwel, A. Munoz, J. Paz-Bouza, J.M. Lopez-Novoa, and F. Lozano Endoglin as a marker in cervical paragangliomas Head Neck 32 2010 737 743
29. A.B. Sandler, J.H. Schiller, and R. Gray Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with carboplatin and paclitaxel plus bevacizumab J Clin Oncol 27 2009 1405 1412
30. E.M. Marom, C.H. Martinez, and M.T. Truong Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer J Thorac Oncol 3 2008 351 357
31. F. Alliot, J. Rutin, P.J. Leenen, and B. Pessac Pericytes and periendothelial cells of brain parenchyma vessels co-express aminopeptidase N, aminopeptidase A, and nestin J Neurosci Res 58 1999 367 378
32. M. Kawamoto, T. Ishiwata, and K. Cho Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer Hum Pathol 40 2009 189 198
33. N. Teranishi, Z. Naito, and T. Ishiwata Identification of neovasculature using nestin in colorectal cancer Int J Oncol 30 2007 593 603
34. R.G. Tilton, P.L. Hoffmann, C. Kilo, and J.R. Williamson Pericyte degeneration and basement membrane thickening in skeletal muscle capillaries of human diabetics Diabetes 30 1981 326 334
35. L. Crino, E. Dansin, and P. Garrido Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study Lancet Oncol 11 2010 733 740